Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-955-3 | CAS number: 22397-58-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation assay (Ames / OECD guideline 471): negative
In vitro mammalian cell gene mutation assay (MLA / OECD guideline 476):
negative
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Refer to the Analogue Approach Justification document provided in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Statistics:
- No.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- C12-14AS Zn is not considered to be mutagenic in bacteria with or with metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Refer to the Analogue Approach Justification document provided in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- -S9: 70, 80 and 90 µg/mL; +S9: 95 µg/mL
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- C12-14AS Zn was not considered to be mutagenic, neither in the presence nor in the absence of metabolic activation.
Referenceopen allclose all
RESULTS OF EXPERIMENTS 1-8
Eight acceptable experiments were conducted, five in the absence of S9 mix.
In the first of these, statistically significant increases in mutant fraction were observed at three dose levels: 6.25, 25, and 50 µg/mL; 100 µg/mL was a lethal concentration in cells (see Table 1). Over the nonlethal range, there were generally elevated mutant fractors, the highest being 1.9-fold the control level at 25 µg/mL. Although these increases in mutant fraction were significant, the lack of an obvious dose-related response with a relatively soluble chemical over a dose range which was not toxic encouraged speculation that the increases were not due to treatment with the test material.
Table 1. Experiment 1 - 4 h exposure - Without Metabolic Activation
Concentration [µg/mL] |
Cloning efficiency |
Relative Total Growth |
Mutants per 1E+06 surviving cells |
Mutation factor |
Average Mutation factor |
|
DMSO (NC) |
62 |
95 |
56 |
30 |
43 |
|
68 |
98 |
90 |
44 |
|||
65 |
95 |
66 |
34 |
|||
80 |
112 |
153 |
64 |
|||
3.125 |
77 |
106 |
84 |
36 |
61 |
|
59 |
97 |
151 |
85 |
|||
6.25 |
71 |
119 |
176 |
83 |
78* |
|
73 |
107 |
160 |
74 |
|||
12.5 |
90 |
145 |
133 |
49 |
65 |
|
67 |
133 |
160 |
80 |
|||
25 |
84 |
90 |
247 |
99 |
83* |
|
65 |
88 |
130 |
67 |
|||
50 |
86 |
82 |
192 |
75 |
69* |
|
76 |
98 |
145 |
64 |
|||
100 |
lethal |
lethal |
n.a. |
n.a. |
n.a. |
|
n.a. |
n.a. |
|||||
MMS (15 µg/mL) PC |
27 |
21 |
135 |
167 |
232* |
|
25 |
23 |
219 |
298 |
MMS = methylmethanesulfonate; NC = negative control; PC = positive control; *p < 0.05; n.a. = not applicable
In the second experiment without S9 mix, there was a clearly significant response at 60 µg/mL, but at no other concentration. The RTG was about 22%
Table 2. Experiment II - 4 h exposure - Without Metabolic Activation
Concentration [µg/mL] |
Cloning efficiency |
Relative Total Growth |
Mutants per 1E+06 surviving cells |
Mutation factor |
Average Mutation factor |
|
DMSO (NC) |
80 |
100 |
115 |
48 |
48 |
|
74 |
108 |
119 |
53 |
|||
86 |
106 |
115 |
45 |
|||
61 |
87 |
83 |
45 |
|||
10 |
75 |
112 |
107 |
47 |
58 |
|
66 |
94 |
137 |
69 |
|||
20 |
67 |
89 |
119 |
59 |
52 |
|
53 |
76 |
70 |
44 |
|||
30 |
71 |
70 |
98 |
46 |
60 |
|
64 |
86 |
144 |
75 |
|||
40 |
77 |
77 |
126 |
54 |
n.a. |
|
50 |
94 |
61 |
191 |
68 |
74 |
|
68 |
56 |
163 |
80 |
|||
60 |
81 |
27 |
365 |
150 |
203* |
|
77 |
16 |
595 |
256 |
|||
70 |
lethal |
lethal |
n.a. |
n.a. |
n.a. |
|
n.a. |
n.a. |
|||||
MMS (15 µg/mL) PC |
34 |
30 |
683 |
666 |
664* |
|
29 |
27 |
573 |
662 |
MMS = methylmethanesulfonate; NC = negative control; PC = positive control; *p < 0.05; n.a. = not applicable
Experiment 3 gave a statistically significant response (1.7-fold increase) at 60 µg/mL, but not at the next higher concentration of 65 µg/mL. The mutant fraction at 70 µg/ml was only 44/106 survivors, so this single culture result supported the view that the statistically significant result at the lower dose level was a chance event. Thus, this experiment was judged to be questionable.
Table 3. Experiment 3 - 4 h exposure - Without Metabolic Activation
Concentration [µg/mL] |
Cloning efficiency |
Relative Total Growth |
Mutants per 1E+06 surviving cells |
Mutation factor |
Average Mutation factor |
|
DMSO (NC) |
76 |
103 |
84 |
37 |
34 |
|
71 |
104 |
73 |
34 |
|||
82 |
97 |
98 |
40 |
|||
74 |
96 |
58 |
26 |
|||
50 |
60 |
71 |
65 |
36 |
36 |
|
75 |
75 |
82 |
36 |
|||
55 |
68 |
44 |
68 |
33 |
38 |
|
53 |
71 |
69 |
44 |
|||
60 |
72 |
63 |
107 |
50 |
56* |
|
72 |
74 |
134 |
62 |
|||
65 |
64 |
71 |
87 |
45 |
42 |
|
79 |
68 |
93 |
39 |
|||
70 |
80 |
83 |
107 |
44 |
n.a. |
|
MMS (15 µg/mL) PC |
36 |
26 |
127 |
119 |
158* |
|
26 |
23 |
156 |
197 |
MMS = methylmethanesulfonate; NC = negative control; PC = positive control; *p < 0.05; n.a. = not applicable
However, the succeeding experiments 4 and 5 without S9 mix were unambiguously negative; therefore the test substance was considered to be non-mutagenic in the absence of S9 mix.
Two experiments (6 and 7) were performed in the presence of S9 mix, showing unambiguously negative results. The last experiment with S9 mix was inconclusive because the cloning efficiency at 80 µg/mL was about 86% and there was no indication of a mutagenic response. However, based on the two experiments with S9 mix showing clearly negative results, the test substance was considered to be not mutagenic in the presence of S9 mix.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Mammalian Bone Marrow Chromosome Aberration Test (CA / OECD guideline 475): negative
Mammalian Erythrocyte Micronucleus Test (MNT / OECD guideline 474): negative
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- Refer to the Analogue Approach Justification document provided in Section 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- C12-14AS Zn was not considered to be produce chromosome aberrations in vivo.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- According to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
- Justification for type of information:
- Refer to the Analogue Approach Justification document provided in Section 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Interpretation of results: negative
C12-14AS Zn was not considered to be clastogenic. - Executive summary:
No increase in micronucleated polychromatic erythrocytes was observed in this micronucleus test. Therefore, the test substance was not considered to be clastogenic.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The lack of mutagenic activity for the alkyl sulfate analogues is predictable based on structural and mechanistic considerations. Mutagens are chemicals that either 1) contain highly reactive electrophilic centers capable of interacting with nucleophilic sites on DNA (direct acting agents) or 2) can be metabolized to highly reactive electrophiles. The chemical structures represented by this chemical class do not contain electrophilic functional groups or functional groups capable of being metabolized to electrophiles. Alkyl sulfates with fully saturated carbon chains are not metabolized to reactive electrophiles. The consistent lack of mutagenic activity with alkyl sulfates is consistent with these mechanistic predictions.
There is no study regarding genotoxicity available for C12-14 AS Zn (CAS n.a.). Therefore this endpoint is covered by read across to structurally related alkyl sulfates (AS) for weight-of-evidence approach, i.e. C12-14 AS Na (CAS 85586-07-8), C12 AS Na (CAS 151-21-3), C12-15 AS Na (CAS 68890-70-0) and C12-14 AS TEA (CAS 90583-18-9). The possibility of a read-across to other alkyl sulfates in accordance with Regulation (EC) No 1907/2006 Annex XI 1.5 “Grouping of substances and read-across approach” was assessed. In Annex XI 1.5 it is given that a read-across approach is possible for substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity. The AS reported within the AS analogues show structural similarity. The most important common structural feature of the members of the analogue approach is the presence of a predominantly linear aliphatic hydrocarbon chain with a polar sulfate group, neutralized with a counter ion. This structural feature confers the surfactant properties of the alkyl sulfates. The surfactant property of the members of the AS analogues in turn represent the predominant attribute in mediating effects on mammalian health. Therefore, the AS of the AS analogues have similar physicochemical, environmental and toxicological properties, validating the read-across approach. The approach of grouping different AS for the evaluation of their effects on human health and the environment was also made by the OECD in the SIDS initial assessment profile [1] and by a voluntary industry program carrying out Human and Environmental Risk Assessments (HERA [2]), further supporting the read across approach between structurally related AS.
Zinc compounds are recognised as zinc category in the OECD HPV program [3]. The zinc category includes six compounds (zinc metal, zinc oxide, zinc distearate, zinc chloride, zinc sulphate, and trizinc bis(orthophosphate). Available data show that zinc salts have moderate effects upon acute oral application and may be irritating to skin and eyes. No genotoxic potential in vivo is reported for the above mentioned zinc salts. Therefore, contribution of zinc to the endpoint genotoxicity is considered to be negligible when assessing human health effects of C12-14AS Zn (CAS n.a.).
Mutagenicity in bacteria
Mutagenicity in bacteria was assessed in a study performed according to OECD Guideline 471. Tester strain TA 102 or E.coli were not used during the conduct of the study (Kao, 1996). In this study with C12-14 AS Na (CAS 85586-07-8), Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 1538 and TA 100 were treated with and without addition of a rat liver S9-mix. The dose range was 5, 15, 50, 150, 500, and 1500 µg/plate without and 5, 15, 50, 150, 500, 1500 and 5000 µg/plate with metabolic activation in the first experiment as well as 5, 15, 50, 150, 500, and 1500 µg/plate (with and without S9 mix) in the second experiment. Results achieved with vehicle (DMSO) and positive controls were valid. Cytotoxicity was observed in presence and absence of metabolic activation at 1500 µg/plate while no genotoxicity was observed.
Mutagenicity in mammalian cells
The mutagenicity of C12 AS Na (CAS 151-21-3) in a mammalian cell line was investigated similar to OECD guideline 476 using the mouse lymphoma L5178Y cells with and without metabolic activation (McGregor, 1988). The test concentrations were 3.125, 6.25, 10, 12.5, 20, 25, 30, 40, 50, 55, 60, 65, 70, 80 and 100 µg/mL without and 50, 55, 60, 65, 70, 75, 80, 85, 90 and 95 µg/mL with metabolic activation. Results achieved with the negative (untreated), vehicle (DMSO) and positive controls were valid. Cytotoxicity was observed in presence and absence of metabolic activation while no genotoxicity was observed under both circumstances.
Clastogenicity in vivo
The potential of C12-14 AS TEA (CAS 90583-18-9, analytical purity approx. 41%) to induce micronuclei in vivo was assessed in a study conducted according to OECD guideline 474 with CFW-1 mouse (BASF, 1987). The test substance was administered via gavage at doses of 400, 2000 and 4000 mg/kg bw to 7 animals per sex and dose. Bone marrow was sampled 24 h (400 and 2000 mg/kg bw) and 24, 48 and 72 h (4000 mg/kg bw) after gavage. Results achieved with the vehicle (DMSO) and positive controls were valid. No signs of toxicity were noted. As no enhanced chromosome aberrations were observed in this micronucleus test the test substance was considered to be not clastogenic.
The potential of C12-15 AS Na (CAS 68890-70-0, analytical purity approx. 30%) to induce in vivo chromosomal aberration was assessed in a study conducted similar to OECD guideline 475 in rats (Unilever, 1976). The test substance was administered via feed at a dose of 1.13% for a period of 90 days to 6 animals per sex and dose and bone marrow was sampled thereafter. Results achieved with the vehicle (DMSO) and positive controls were valid. No signs of toxicity were noted. As no enhanced chromosome aberrations were observed in this chromosomal aberration test the test substance was considered to be not clastogenic.
In conclusion, the read across substances did not show any genotoxic potential. This is supported by the conclusions of the HERA Draft report “AS are not genotoxic, mutagenic or carcinogenic…” and the conclusions of the SIDS initial assessment profile “Alkyl sulfates of different chain length and with different counter ions were not mutagenic in standard bacterial and mammalian cell systems [...]. There was also no indication for a genotoxic potential of alkyl sulfates in various in vivo studies on mice […].”
[1] SIDS initial assessment profile, (2007); http://www.aciscience.org/docs/Alkyl_Sulfates_Final_SIAP.pdf
[2] (HERA Draft report, 2002); http://www.heraproject.com/files/3-HH-04-%20HERA%20AS%20HH%20web%20wd.pdf
[3] SIDS initial assessment profile, (2005);http://webnet.oecd.org/Hpv/UI/handler.axd?id=fddec5fa-9727-413a-9d67-41c2154cd362
Justification for classification or non-classification
The available data on genetic toxicity do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.